Explore 3 Stock Ideas & Industry Insights Download Free Report

Diagnamed Holdings Corp.

Healthcare US DGNMF

0.0322USD
-0.0044(12.02%)

Last update at 2026-06-22T17:41:00Z

Day Range

0.030.03
LowHigh

52 Week Range

0.010.19
LowHigh

Fundamentals

  • Previous Close 0.04
  • Market Cap7.45M
  • Volume10000
  • P/E Ratio-
  • Dividend Yield-%
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM -0.01871M
  • Diluted EPS TTM-0.01

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Type yearly yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Income before tax -1.40315M -0.50106M -1.27794M -1.13243M -1.94782M
Minority interest - - - - -
Net income -1.40315M -0.50106M -1.27794M -1.13243M -1.94782M
Selling general administrative 0.61M 0.43M 0.82M 0.57M 0.48M
Selling and marketing expenses - - - - -
Gross profit - - - - -
Reconciled depreciation - - - - -
Ebit - - - -1.12969M -0.68367M
Ebitda - - - -1.13569M -0.68367M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -1.48964M -0.74124M -1.25292M -1.13569M -0.68367M
Other operating expenses - - - - -
Interest expense - - - - -
Tax provision - - - - -
Interest income 0.00261M 0.00867M 0.00589M - -
Net interest income 0.00261M 0.00867M 0.00589M - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Total operating expenses 1.49M 0.74M 1.25M 1.14M 0.68M
Cost of revenue - - - - -
Total other income expense net 0.08M 0.23M -0.03091M 0.00326M -1.26415M
Discontinued operations - - - - -
Net income from continuing ops -1.40315M -0.50106M -1.27794M -1.13243M -1.94782M
Net income applicable to common shares - - - -1.13243M -1.94782M
Preferred stock and other adjustments - - - - -
Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Type yearly yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Total assets 0.22M 0.20M 0.66M 1.62M 2.39M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets - - - - -
Total liab 0.67M 0.47M 0.43M 0.37M 0.15M
Total stockholder equity -0.45011M -0.26517M 0.24M 1.25M 2.24M
Deferred long term liab - - - - -
Other current liab - - - - -
Common stock - - - 3.17M 3.11M
Capital stock 4.28M 3.57M 3.57M 3.17M 3.11M
Retained earnings -6.26239M -4.85924M -4.35818M -3.08025M -1.94782M
Other liab - - - - -
Good will - - - - -
Other assets - - - - -
Cash 0.18M 0.16M 0.61M 1.57M 2.36M
Cash and equivalents - - - - -
Total current liabilities 0.67M 0.47M 0.43M 0.37M 0.15M
Current deferred revenue - - - - -
Net debt - - - - -
Short term debt - - - - -
Short long term debt - - - - -
Short long term debt total - - - - -
Other stockholder equity - - - 1.00M 1.06M
Property plant equipment - - - - -
Total current assets 0.22M 0.20M 0.66M 1.62M 2.39M
Long term investments - - - - -
Net tangible assets - - - 1.25M 2.24M
Short term investments - - - - -
Net receivables 0.02M 0.03M 0.06M 0.05M 0.03M
Long term debt - - - - -
Inventory - - - - -
Accounts payable - - - 0.37M 0.15M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Type yearly yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Investments - - - - 0.03M
Change to liabilities - - - 0.22M 0.15M
Total cashflows from investing activities - - - - 0.03M
Net borrowings - - - - -
Total cash from financing activities 0.36M 0.00000M 0.10M 0.00000M 2.89M
Change to operating activities - - - - -
Net income -1.40315M -0.50106M -1.27794M -1.13243M -1.94782M
Change in cash 0.02M -0.44482M -0.96326M -0.78758M 2.36M
Begin period cash flow 0.16M 0.61M 1.57M 2.36M 0.00000M
End period cash flow 0.18M 0.16M 0.61M 1.57M 2.36M
Total cash from operating activities -0.33607M -0.44482M -1.06751M -0.78758M -0.56560M
Issuance of capital stock - - - 0.00000M 2.89M
Depreciation - - - - -
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables 0.01M 0.02M -0.00997M -0.01317M -0.03217M
Sale purchase of stock - - - - -
Other cashflows from financing activities - - - - -0.07610M
Change to netincome - - - 0.14M 1.26M
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.35M 0.27M 0.15M 0.21M 0.12M
Stock based compensation 0.30M 0.00000M 0.01M 0.14M 0.00000M
Other non cash items 0.52M - - - 1.26M
Free cash flow -0.33607M -0.44482M -1.06751M -0.78758M -0.56560M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to EBITDA (x)
DGNMF
Diagnamed Holdings Corp.
-0.0044 12.02% 0.03 - - - 14.62 -1.9797
VEEV
Veeva Systems Inc Class A
-0.14 0.09% 153.16 54.61 33.22 12.83 6.73 11.14 58.84
MTHRF
M3 Inc
- -% 8.55 29.72 25.00 0.05 4.38 0.04 0.12
MTHRY
M3 Inc
0.18 3.58% 5.21 31.84 26.25 0.05 4.60 0.04 0.12
BTSG
BrightSpring Health Services, Inc. Common Stock
0.95 1.43% 67.20 100.22 40.65 0.69 4.92 0.92 25.80

Reports Covered

Stock Research & News

Profile

Diagnamed Holdings Corp. engages in the development and commercialization of AI healthcare solutions. The company focuses on developing BRAIN AGE BRAIN HEALTH, a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It has a collaboration agreement with EIREX for the development and commercialization of EIREX's novel modular carbon-free technology that extracts hydrogen from water. Diagnamed Holdings Corp. is headquartered in Toronto, Canada.

Diagnamed Holdings Corp.

82 Richmond Street East, Toronto, ON, Canada, M5C 1P1

Key Executives

Name Title Year Born
Mr. Andre Turmel Independent Executive Chairman NA
Mr. John Karagiannidis President, CEO & Director NA
Mr. Edward Low Interim Chief Financial Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.